Mithril Medicine Overview
- Year Founded
-
2024
- Status
-
Acquired/Merged
- Employees
-
1
- Latest Deal Type
-
M&A
- Investors
-
2
Mithril Medicine General Information
Description
Developer of multispecific antibodies designed for the treatment of rare genetic diseases. The company is currently operating in Stealth mode.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
- Cambridge, MA
- United States
Primary Industry
Drug Delivery
Vertical(s)
Corporate Office
- Cambridge, MA
- United States
Mithril Medicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 27-Oct-2026 | Completed | Stealth | |||
| 1. Accelerator/Incubator | 01-Jan-2026 | Completed | Stealth |
Mithril Medicine Signals
Mithril Medicine FAQs
-
When was Mithril Medicine founded?
Mithril Medicine was founded in 2024.
-
Where is Mithril Medicine headquartered?
Mithril Medicine is headquartered in Cambridge, MA.
-
What is the size of Mithril Medicine?
Mithril Medicine has 1 total employees.
-
What industry is Mithril Medicine in?
Mithril Medicine’s primary industry is Drug Delivery.
-
Is Mithril Medicine a private or public company?
Mithril Medicine is a Private company.
-
What is Mithril Medicine’s current revenue?
The current revenue for Mithril Medicine is .
-
When was Mithril Medicine acquired?
Mithril Medicine was acquired on 27-Oct-2026.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process